David Meads

Health Economist, University of Leeds. Views and tweets are personal

[NICE @NICEComms]

We're consulting on updated methods for our healthtech guidance, including new approaches for late-stage assessment of technologies already in widespread NHS use.

Have your say and help shape how we evaluate digital health and AI technologies⬇️

https://t.co/lBEHdQDoc6

[Andrew Clegg @drandyclegg]

Fab new job opportunity!! 4 1/2 year SRF/RF Statistician post to take a leading role in @NIHRresearch funded Individual Participant Data Meta-Analysis (IPDMA) of ageing research trials https://t.co/dkDkU4vc3t Joint @AUASResearch and @ComplexCTRU post, with @amanda_horler and me

[David Meads @DMeadster]

Critical funding opportunity to evaluate strategies for moving care from hospital to community….👇

[National Institute for Health and Care Research @NIHRresearch]

Opening soon: Hospital at home/virtual wards: integration opportunities, improving service delivery and evaluating impact https://t.co/nzSPA8AVFf

[National Institute for Health and Care Research @NIHRresearch]

We are launching a new #fundingopportunity to support the development of innovative health technologies aimed at reducing waiting times and waiting lists.

🖥️ Join our launch webinar on 8 April 2025, 3pm - 4:30pm to find out more: https://t.co/quQ6oxJzEo

[CHORUS Urban Health @ChorusUrban]

A week-long workshop on #economicevaluation in healthcare, with CHORUS teams from @arkfoundation1 @HERDIntl @BRACJPGSPH. Putting learning into practice with facilitation from @Bryonyd2 @Zahid_Quayyum
A great health economics team!

[David Sebag (he/him) 🇺🇦💙 @MontefioreD]

Huge congratulations to @katiespencer72, a Clinical Oncologist , one of six rising stars in the UK to be awarded a @HDR_UK fellowship within the Big Data for Complex Disease programme
👉https://t.co/MuHGIM1InR
#canceresearch #healthinequalities

@UniversityLeeds
@LeedsHospitals

[Kara-Louise Royle @KaraRoyle]

🎉 Exciting news!

💻 Applications are open for UG Data Science Summer Interns @LeedsCTRU

✏️Full details https://t.co/o7lQ1nZrT3

3️⃣Three projects available with me, @lesleyfairley and @bethan_copsey

🔁 Please retweet and share with students!

[ApolloChoiceModelling @ApolloChoice]

Two weeks left to apply for our 3 postdoctoral positions at the interface of choice modelling, machine learning and mathematical psychology (all for 3 years). Full details at https://t.co/QMy7Orpa3A

[David Meads @DMeadster]

@kennycairns @LeedsCTRU Excellent news - congratulations David

[Edward JD Webb @Beardy_Econ]

Out now in @AACjourn, "Something for everybody? Assessing the suitability of AAC systems for children using stated preference methods" https://t.co/efTOA9lgn7

[Rebecca Walwyn @RebeccaWalwyn]

I am now gearing up to advertise for a post-doc research fellow and a PhD student linked to my NIHR Advanced Fellowship. If you think you might be interested, please do get in touch.

[Edward JD Webb @Beardy_Econ]

Available online now in The Patient! Our study linking how well people with relapsing MS' choices for hypothetical disease modifying treatments in a DCE correlate with the DMTs they take in real life https://t.co/EfhTUCacMY

[Edward JD Webb @Beardy_Econ]

On a serious note, I'm very proud of our paper here: https://t.co/h0QnyAKyTR It's the first DCE to look at how reproductive issues impact women with multiple sclerosis' preferences for disease modifying treatments, with important implications for prescribing around pregnancy.

[EuroQol @EuroQol]

After successfully completing a pilot phase of the new EQ-5D-5L valuation study for the UK, the data collection has been initiated and expected to end at the end of Summer 2023.

For more information about the study please visit our blog 👉https://t.co/KjshCd2lOd

#EQ5D #EQ5D5L

[Edward JD Webb @Beardy_Econ]

Out now in the European Journal of Health Economics! A paper with @Quality_Outcome, @DMeadster and @Adam_Mart1n on whether and how EQ-5D-5L valuation was affected by COVID-19.
https://t.co/HNHtK7tdqf

[Ruben Mujica-Mota @R_Mujica_Mota]

Intrigued by the prospect of breaking the disciplinary boundaries at the intersection of data science, economics, mathematical modelling and genetic epidemiology within an expanding national biomedical research centre? If so, this advert may be for you. We are looking for

[David Meads @DMeadster]

https://t.co/i3Ozra7v95

STAR - trial of 1st line TKI cessation (vs continuous treatment) in advanced renal cell carcinoma is now out in Lancet Oncology.
One of few trials ever to include the QALY as a (co-)primary end-point

[Deena Harji @DeenaHarji]

Thank you to everyone for the kind messages. Watch this space for the #EMERALD 💚 project @NIHRresearch @LeedsCTRU @MFTnhs @LeedJulia @StockenDeborah @rupert_pearse @BlazebyJ @nikki_rou @drsusannec @DMeadster

[Adam Martin @Adam_Mart1n]

📢📢 @AUHE_Leeds are recruiting

➡️Two health economics / health data science G6-G7 positions

➡️Main focus is analysing observational datasets

➡️Working with @Beardy_Econ @srkingsbury @DMeadster @Louisa_Ells & me

Deadline 31 January https://t.co/j3JcQ8k90J

[Understanding Society @usociety]

The Understanding Society Fellowship programme has just opened for applications - funding for a 12-month project with direct impact https://t.co/FT9rYEdF50